A. Materials and methods Reagents: All reagents were of analytical grade (purity > 98%) and were purchased from Sigma-Aldrich Chemical Co. unless otherwise specified. SSG (1) was purchased from Wako Pure Chemical Industries, Ltd. Diosgenin (6), Dioscin (9), Polyphyllin D (10), Timosaponin BI (22) and Timosaponin BII (23) were purchased from Chengdu Must Bio-Technology Co.
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Fig. S14 Molecular docking of SSG, TAI, TAIII and cholesterol to the transmembrane domain of APP.
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was performed at least three times. The lowest binding scores were computed and the conformations of the corresponding binding pose presented.
Quantum mechanics/Molecular mechanics. The binding between transmembrane and substrate was further optimized using the QM/MM approach and NWChem software. The quantum part (QM) included TAIII (total 116 atoms), while the rest of the system was modelled as the molecular mechanics (MM) level. The QM region was treated at the DFT level using the B3LYP method. The 6-31G* Pople basis set was employed for all the atoms.
The transmembrane was described with the AMBER parm99 force field. The binding structure was solvated in a cubic box with 6872 classical SPC/E water molecules. Three negative counter ions (Cl -) were added to neutralize the charges in the system. The structure was optimized by performing the BFGS algorithm for the QM part and the steepest descent algorithm for the MM part. The optimization of these two regions (QM and MM) was alternated until self-consistency was reached.
Animal experiments: Male C57BL/6N mice were housed in environmentally controlled room (temperature: 25  2 o C, humidity: 50  5%, 12-h light-dark cycle) in Laboratory Animal Unit, The University of Hong Kong and were freely access to food and water. TAIII, TAI SSG and compound 34 were dissolved in 5% Tween 80 and given to the mice by oral gavage at three repeated doses of 100 mg/kg in 48 hours. Mice were administrated with 5% were collected into two separate data channels with the instrument spending 0.5 s on data acquisition for each channel and a 0.1 s inter-channel delay. The mass spectrometer was calibrated by using the solution of sodium formate (0.5 mM) and the TOF scan range was from 100 to 1000 Da. In order to improve mass measurement accuracy a lock mass compound (50 pg L −1 solution of leucine encephalin; m/z 556.2771) was continuously infused at a 0.5 mL min -1 using the built-in syringe pump of the instrument.
UPLC condition
Sample was loaded into a Waters ACQUITY TM BEH C 18 column (100 × 2.1 mm i.d., 1.7 µM)
connected to a Waters ACQUITY TM BEH C 18 guard column (5 × 2.1 mm i.d., 1.7 µM). The gradient elution system consisted of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). Separation was achieved by using: 30%-55% B from 0 to 3 min; 55-100% B from 3 to 6 min; 100% B from 6 to 12 min and returned to initial conditions and equilibrated for 3 minutes. The flow rate was 0.3 mL/min and the injection volume was 5 µL. dryness by a concentrator. Dioscin (20 µL , 10 µM) was added as an internal standard followed by methanol (130 µL) and control plasma (50 µL). The mixture was vortexed for 5 s and centrifuged (15000 × g) for 15 min. The supernatant was collected and evaporated to dryness by a concentrator. Methanol (100 µL) was added and then vortexed again for 10 s and centrifuged (15000 × g) for 20 min. The supernatant (5 µL) was subject to LC-MS/MS analysis. Analyte-treated plasma, control brain and analyte-treated brain were prepared in a similar manner.
Standard preparation and sample preparation

Data acquisition
The acquisition and processing of data were performed by Masslynx (version 4.1) software.
Mass window of 10 mDa and mass resolution of 9000 were set for both molecular ions and product ions. 
Preparation of Timosaponin
Preparation of Capsicoside A 3 (8)
Capsicoside A (13) and Neotigogenin (14) .
Preparation of Tigogenin (13) and Neotigogenin (14) by hydrogenation
Fig. S6: Synthesis of Tigogenin
Hydrogenation of diosgenin (6) and yamogenin (7) was referenced to published report. 9 (a) To a solution of diosgenin (6) (10 mg, 0.024 mmol) dissolved in MeOH (15 mL) was added Pd/charcoal (5%, 3 mg) as a catalyst. H 2 was bubbled in and stirred at room temperature for 3 h. Filtered and dried to obtain tigogenin (13) (quantitative yield).
-69 (c 0.53, CH 2 Cl 2 ). 
Preparation of 5α-H, 6α-OH and 5-H, 6-OH of diosgenin (15-16) and 5α-H, 6α-OH and 5-H, 6-OH of yamogenin (17-18).
Diosgenin, R for C 25 (6) Yamogenin, S for C 25 ( The synthesis of compounds 15-18 was referenced to publication.
10
(a) To a solution of diosgenin (6) (125 mg, 0.3 mmol) in anhydrous CH 2 Cl 2 (15 mL) at 0 °C, benzoyl chloride (65 mg), Et 3 N (50 mg) and DMAP (10 mg) were added subsequently.
The reaction mixture was warmed to room temperature gently and monitored by TLC (~ 8 h). The mixture was concentrated under reduced pressure and the residue was subjected to column chromatography using EtOAc/n-hexane as eluent to obtain 3-benzoylated diosgenin (Yield: 85% (b) Episarsasapogenin was prepared according to literature. 12 To a solution of sarsasapogenone (19) (50 mg, 0.12 mmol) in THF (1.5 mL) at room temperature was added lithium tri-tert-butoxyaluminohydride (0.16 mL, 1M in THF) at such a rate that the temperature was maintained. After the addition was complete, the mixture was stirred at room temperature overnight. TLC (CH 2 Cl 2 :EtOAc=10:1) indicated that all sarsasapogenone was consumed. Saturated NH 4 Cl solution was added to quench the reducing reagent. The mixture was filtered and the solid was washed with CH 2 Cl 2 . The S20 combined filtrates were extracted with CH 2 Cl 2 and the organic layer was evaporated to afford a crude product which was subjected to column chromatography using CH 2 Cl 2 : (c) To a solution of SSG (1) (42 mg, 0.1 mmol) in anhydrous DMF (3 mL), NaH (0.5 mmol)
was added at 0 C and the mixture was stirred at this temperature for 0.5 h. Then, propargyl bromide (1.0 mmol) was added and the mixture was stirred at room temperature for 3 d. The reaction mixture was diluted with 100 mL of diethyl ether and drops of H 2 O was added to quench the unreacted NaH, and then, the diethyl ether fraction was washed successively with water, brine, dried with MgSO 4 , and concentrated under reduced pressure. The residue was subject to column chromatography using EtOAc/n-hexane as eluent to afford propargyl SSG (25) Tables and Figures   Table S1 . Some A lowering compounds from natural products 
